Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice
Nutrients · 23.04.2026 · 18 (9) · 1335
DOI: 10.3390/nu18091335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 23.04.2026. Verfasst von Tingchao He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Lacticaseibacillus rhamnosus, Probiotics. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Beijing Natural Science Foundation, Grants-in-Aids for Young Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) is a chronic inflammatory skin disease linked to epidermal barrier dysfunction, Th2-skewed immune polarization, and disrupted gut microbiota homeostasis. While probiotic interventions show promise in managing AD, the mechanisms governing strain-specific efficacy—particularly systemic modulation via the “gut–skin axis”—remaining to be fully elucidated.
Methods
This study systematically compared the oral therapeutic effects of three Lacticaseibacillus rhamnosus strains (MG-A047, MG-A054, and LGG) in a 2,4-dinitrochlorobenzene (DNCB)-induced AD mouse model.
Results
By integrating behavioral, histopathological, and serological assessments with 16S rRNA-based gut microbiota profiling and in vitro functional assays, this study offers a multidimensional evaluation of the strain-specific advantages and potential therapeutic mechanisms of three L. rhamnosus strains. The results demonstrate that MG-A054 most effectively alleviated cutaneous inflammation and pruritus, significantly reduced serum IgE and IL-4 levels, and attenuated epidermal hyperplasia and inflammatory cell infiltration (including mast cells and eosinophils). Mechanistically, this strain may directly inhibit hyaluronidase activity and mast cell degranulation, and specifically remodel the gut microbiota structure, thereby promoting a shift toward a healthier functional profile.
Conclusions
These findings suggest that the superior efficacy of MG-A054 may be achieved through coordinated modulation of the gut–skin axis and related pathways. This study offers new mechanistic clues for understanding the strain-specific actions of probiotics and lays a preclinical foundation for the further development of MG-A054 as a potential targeted microecological therapy for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China.
- Department of Hygiene, Fujita Health University, Toyoake-shi 470-1192, Japan.
- Mom's Garden Institute of Nutrition and Health, Bismarckstraße 37, 66121 Saarbrücken, Germany.
- School of Nursing, Peking University, Beijing 100191, China.
ORCID-Profile: Tingchao He, Hua Jiang, Yumei Zhang
Förderung
- National Key Research and Development Program of China
- Beijing Natural Science Foundation
- Grants-in-Aids for Young Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
He, T., Lu, Q., Zhang, J., Xie, X., Liu, X., Jiang, H., Li, J., & Zhang, Y. (2026). Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice. Nutrients, 18(9), 1335. https://doi.org/10.3390/nu18091335
Vancouver
He T, Lu Q, Zhang J, Xie X, Liu X, Jiang H, et al. Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice. Nutrients. 2026;18(9):1335. doi:10.3390/nu18091335
BibTeX
@article{He2026,
author = {He, Tingchao and Lu, Qidong and Zhang, Jian and Xie, Xinyu and Liu, Xin and Jiang, Hua and Li, Jing and Zhang, Yumei},
title = {Therapeutic Potential of Specific Lacticaseibacillus rhamnosus Strains for DNCB-Induced Atopic Dermatitis in Mice},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {9},
pages = {1335},
doi = {10.3390/nu18091335}
}
EUVIMED